Baytril® Otic (enrofloxacin/silver sulfadiazine) Emulsion

When nasty canine otitis externa strikes, you need a powerful treatment option. Baytril Otic combines enrofloxacin and silver sulfadiazine (SSD) to fight Pseudomonas ear infections effectively.

Order Now
Product Label

Why Choose Baytril Otic?

  • Icon illustrating the combination of Enroflaxacin and Silver Sulfadiazine

    The only otic preparation that combines two active ingredients effective against Pseudomonas

  • Illustration of a dog ear with an arrow pointing down the ear canal

    Emulsions can distribute deep into the ear canal

  • An illustrated silhouette of an upturned bottle with a droplet coming out

    Gentle on the ears, easy to administer and low-mess

  • A purple illustrated syringe lies in front of several silhouetted bottles

    Part of the trusted Baytril® family

Baytril Otic Product Information

Blue check mark
Indication

Treatment of canine otitis externa

Blue check mark
Formulation

Topical

Blue check mark
Active Ingredients

Enrofloxacin, Silver Sulfadiazine

Blue check mark
Broad Spectrum

Bacteria and yeast

Baytril Otic Dosing information

Weight of Dog - 35 lbs or less
Drops of Baytril Otic -

5-10 drops per treatment

Weight of Dog - Over 35 lbs
Drops of Baytril Otic -

10-15 drops per treatment

How Baytril Otic Works

Two active ingredients, one powerful combination against canine otitis externa

Step 1 : Only Baytril® Otic fights Pseudomonas with two mechanisms of action – enrofloxacin attacks on the inside while silver sulfadiazine attacks on the outside.

Step 2 : Baytril® Otic delivers up to 1,000 times the minimum amount of silver sulfadiazine (SSD) needed to kill tough Pseudomonas in vitro2,*

Baytril Otic is your go-to for fighting Pseudomonas

To place an order, please contact your Elanco Sales Representative.

Baytril® Otic (enrofloxacin/silver sulfadiazine) Emulsion

Indications

Baytril® Otic is indicated as a treatment for canine otitis externa complicated by bacterial and fungal organisms susceptible to enrofloxacin and/or silver sulfadiazine.

Important Safety Information

The use of Baytril® Otic in dogs with perforated tympanic membranes has not been evaluated. Therefore, the integrity of the tympanic membrane should be evaluated before administering this product. If hearing or vestibular dysfunction is noted during the course of treatment, discontinue use. Avoid contact with eyes. In case of contact, immediately flush eyes with copious amounts of water for 15 minutes. The use of Baytril Otic in dogs used for breeding purposes, during pregnancy or in lactating bitches has not been evaluated. Baytril Otic is contraindicated in dogs with suspected or known hypersensitivity to quinolones and/or sulfonamides. During clinical trials, dogs exhibited acute inflammation of the ear canal and pinna. See product label for more information.